XML 58 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Compensation Plan (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2019
Options          
Stock options and Stock Appreciation Rights vested          
Options granted (in shares)       0  
Options vested (in shares)       73,828  
Aggregate grant date fair value of Options vested (in millions)       $ 1.1  
Outstanding Stock Options and Stock Appreciation Rights          
Options outstanding (in shares)       386,053 416,548
Aggregate intrinsic value (in millions)       $ 0.3 $ 3.9
Per share weighted average exercise price (in usd per share)       $ 70.68 $ 70.08
Exercisable Options (in shares)       368,775 318,029
Aggregate intrinsic value (in millions)       $ 0.3 $ 3.9
Unvested Options (in shares)       17,278 98,519
Per share weighted average grant date fair value (in usd per share)       $ 14.61 $ 14.41
Performance Share Units ("PSUs")          
Additional disclosures          
Granted (in shares)       44,206  
Percentage of target to be awarded, low end of range       0.00%  
Percentage of target to be awarded, high end of range       200.00%  
Market price at grant date of performance units (in usd per share)       $ 63.07  
Employees | Restricted Stock Units (RSUs)          
Additional disclosures          
Granted (in shares)       79,977  
Equity instruments other than options, weighted average grant date fair value (in usd per share)       $ 62.04  
Employees | Scenario, Forecast | Vesting Tranche One | Restricted Stock Units (RSUs)          
Additional disclosures          
Award vesting rights     33.33%    
Employees | Scenario, Forecast | Vesting Tranche Two | Restricted Stock Units (RSUs)          
Additional disclosures          
Award vesting rights   33.33%      
Employees | Scenario, Forecast | Vesting Tranche Three | Restricted Stock Units (RSUs)          
Additional disclosures          
Award vesting rights 33.33%        
Directors | Restricted Stock Units (RSUs)          
Additional disclosures          
Granted (in shares)       14,112  
Equity instruments other than options, weighted average grant date fair value (in usd per share)       $ 49.60  
Award vesting period       1 year